DEA Guidelines for Prescribing During COVID-19: How Do You Continue …

Stanford Medicine

S. Pritzlaff

COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifyin…

University of Miami Sylvester Comprehensive Cancer Center

G. Lopes

Update on Treatment and Prevention of COVID-19 in Cancer Patients

Penn Medicine Abramson Cancer Center

A. Garfall

Outcomes of Patients With CLL and COVID-19 Infection

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Chatzikonstantinou

Non-Malignant Hematology: What Have We Learned in 2022

Indy Hematology Review

C. Kessler

COVID-19, Thrombocytopenia & ITP: What is the Effect on Platelet Cou…

James Bussel

Lung Cancer and COVID-19 Updates

Total Health

S. Richey

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

ASCO 2022 Conference Coverage

C. Dang

Perspectives on COVID-19 and Multiple Myeloma Care: New York City, E…

Memorial Sloan Kettering Cancer Center

O. Landgren

COVID-19 & ITP Updates

Platelet Disorder Support Association (PDSA)

T. Gernsheimer

ASH 2021 Clinical Predictors of Outcomes in Adult Acute Leukemias an…

ASH 2021 Conference Coverage on VuMedi

P. Desai

Updates on Thrombosis & COVID-19

ASH 2022 Conference Coverage

B. Hunt

SARS-CoV-2 & ASCO Guidelines: Are Pts With Cancer More Likely to Be …

Stanford Medicine

V. Agarwala

2022 West Oncology Conference Updates on Cancer and COVID-19: What D…

2022 West Oncology Conference

S. Richey

Pearls for Providers on Managing Sickle Cell Disease and COVID-19: W…

Ify Osunkwo

Cardiovascular Impact of COVID-19: What Are the Most Common Post Acu…

American Heart & Vascular Institute

K. Shah

Cancer Care & COVID19: Which Cancer Pts & Which Regimens Are the Hig…

Total Health

M. Pegram

COVID-19 & Remote Delivery of Medical Info and Care: How Does the In…

GRACE

B. Levy, J. Weiss, J. West

COVID-19 and Cancer Patients: Will There Be a Cancer Pandemic After …

Karol Sikora

Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, Hemo…

Zahra Pakbaz